BioLife Sciences (BLFE) Announces the Launch of New Antimicrobial Air Filter Technology
BioLife Sciences Inc. (OTCPK:BLFE) has unveiled a new antimicrobial air filter technology designed to enhance air quality in homes and workplaces. The filters utilize proprietary Mfusion Technology, infusing copper metal ions into the fabric to eliminate bacteria, fungi, and viruses. This technology claims to kill 99.99% of pathogens upon contact. BioLife is focused on advancing innovative products into the market, particularly antimicrobial solutions and non-contact screening technologies. The company aims to broaden the adoption of such technologies through strategic partnerships.
- Launch of new antimicrobial air filter technology utilizing Mfusion Technology.
- Copper-infused filters demonstrate efficacy in killing 99.99% of bacteria, fungi, and viruses.
- Potential for significant market adoption of innovative antimicrobial products.
- None.
Toronto, CA, Oct. 15, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- BioLife Sciences Inc. (OTCPK:BLFE) announced today the launch of their new antimicrobial air filter technology.
BioLife Antimicrobial Air Filters provide consumers with the ability to help sanitize the air in their homes or workspaces, while providing continuous, long-lasting protection for months. The fabric-based BioLife Antimicrobial Copper Air Filter utilizes the company’s proprietary Mfusion Technology.
Mfusion Technology infuses copper metal ions into every sub-bundle of the fabric filter, resulting in natural protection against bacteria and germs, which normally thrive when circulating in an enclosed room, or building. The fabric helps to block out airborne particles, while any germs or viruses which are trapped in the filter fabric will come in contact with the copper ions and become deactivated over time.
Mfusion Technology leverages the natural antimicrobial benefits of copper ions, which have been shown to kill
About BioLife Sciences Inc.
BioLife Sciences Inc. specializes in moving innovative products from the lab or small-scale production into wider market adoption. Its core business develops, licenses and distributes antimicrobial products, non-contact human temperature screening technology, and touchless vending/marketplaces. One of BioLife Sciences’ core building block strategies is to develop, partner and assist innovative companies with the commercialization of leading-edge technologies.
Disclaimer
The information in this news release includes certain information and statements about management's view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to, the ability of the Corporation to complete a qualifying transaction. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Corporation believes that the expectations reflected in forward looking statements are reasonable, it can give no assurance that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Corporation disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.
Contact Information:
ir@biolifesciences.com
US: (775) 981-0270
Canada: (647) 558-6663
FAQ
What is the new product launched by BioLife Sciences Inc.?
How effective is the BioLife antimicrobial air filter?
What technology does the BioLife air filter use?
What market does BioLife Sciences operate in?
What is the stock symbol for BioLife Sciences Inc.?
